Cetek Corporation and M. D. Anderson Cancer Center Announce Research Collaboration.Business Editors/Health/Medical Writers BIOWIRE2K MARLBOROUGH, Mass. and HOUSTON--(BUSINESS WIRE)--Jan. 7, 2004 Cetek Corporation and The University of Texas - M. D. Anderson Cancer Center (M. D. Anderson) announced today that they have signed a collaborative agreement to discover and develop new drugs targeting cancer and inflammatory diseases Noun 1. inflammatory disease - a disease characterized by inflammation disease - an impairment of health or a condition of abnormal functioning NEC, necrotizing enterocolitis - an acute inflammatory disease occurring in the intestines of premature infants; . This collaboration between Cetek and M. D. Anderson presents a unique opportunity to discover and develop potent, small-molecule drugs. Cetek will utilize its extensive natural product technologies including the powerful CE Assay(TM) to identify and isolate isolate /iso·late/ (i´sah-lat) 1. to separate from others. 2. a group of individuals prevented by geographic, genetic, ecologic, social, or artificial barriers from interbreeding with others of their kind. novel, drug-like compounds. Cetek and M. D. Anderson will work together in developing these compounds. "M. D. Anderson is excited with this opportunity to advance natural product drug discovery using Cetek's novel technology platform. This is an excellent complement between a research institute and a leading biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. company to discover new compounds from this established source of anti-cancer and anti-inflammatory compounds," said Dr. Moshe Talpaz, Chairman, Department of Bioimmunotherapy. "We are pleased to be working with M. D. Anderson in this initial collaboration combining Cetek's drug discovery capabilities and M. D. Anderson's clinical expertise. This is an excellent fit for discovering new drugs for these important therapeutic areas," said Dr. Dallas Hughes, Senior VP Technology, Cetek Corporation. Cetek Corporation is a drug discovery company with expertise in finding novel, patentable compounds with drug-like properties from natural extracts. Cetek utilizes several proprietary technologies in a high-throughput "factory" environment. Cetek also collaborates with pharmaceutical companies in taking their targets through Cetek's Natural Product Factory(TM) and delivering high quality, preclinical preclinical /pre·clin·i·cal/ (-klin´i-k'l) before a disease becomes clinically recognizable. pre·clin·i·cal adj. 1. drug-candidates. Cetek focuses on infectious disease Infectious disease A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions. , cancer, diabetes, and Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. . Cetek has collaborations with companies in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. , Europe and Japan. For additional information, visit Cetek's website at http://www.cetek.com or contact Dr. James N. Little, President, at (508) 229-8900 or j.little@cetek.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion